We are live on ! Find out more
EC

Euclidean Capital Portfolio holdings

AUM $392M
1-Year Est. Return 31.85%
This Fund
S&P 500
This Quarter Est. Return
-3.16%
1 Year Est. Return
+31.85%
3 Year Est. Return
+76.27%
5 Year Est. Return
-20.16%
10 Year Est. Return
–
AUM
$108M
AUM Growth
-$9.86M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
10
New
–
Increased
–
Reduced
–
Closed
–

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 96.6%
2 Financials 3.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ME
1
DELISTED
23andMe Holding Co
ME
$29.3M 27.2%
512,156
– –
PMVP icon
2
PMV Pharmaceuticals
PMVP
$59.2M
$27.8M 25.82%
2,336,909
– –
FHTX icon
3
Foghorn Therapeutics
FHTX
$266M
$10.8M 10.05%
1,261,261
– –
RAPT
4
DELISTED
RAPT Therapeutics
RAPT
$10.4M 9.67%
54,113
– –
NGM
5
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$9.77M 9.07%
746,674
– –
ALEC icon
6
Alector
ALEC
$168M
$9.28M 8.61%
980,894
– –
FFBC icon
7
First Financial Bancorp
FFBC
$3.55B
$3.66M 3.4%
173,576
– –
TNYA icon
8
Tenaya Therapeutics
TNYA
$161M
$2.66M 2.47%
915,705
– –
ORIC icon
9
Oric Pharmaceuticals
ORIC
$1.15B
$2.39M 2.22%
747,550
– –
SRZN icon
10
Surrozen
SRZN
$258M
$1.62M 1.51%
53,531
– –

Similar funds

WSC
Wellington Shields & Co New York $392M AUM 30.65% 1-Year Est. Return
RC
Riposte Capital New York $392M AUM 69.08% 1-Year Est. Return
DCM
Divisar Capital Management San Francisco, California $392M AUM 108.45% 1-Year Est. Return
HBWM
Hollow Brook Wealth Management Katonah, New York $392M AUM 36.68% 1-Year Est. Return
BWM
Buckley Wealth Management Las Vegas, Nevada $392M AUM 28.21% 1-Year Est. Return
IPW
Inlet Private Wealth Jupiter, Florida $392M AUM 25.74% 1-Year Est. Return
TCM
Turas Capital Management Boston, Massachusetts $392M AUM
MA
Mezzasalma Advisors Tinton Falls, New Jersey $391M AUM 40.85% 1-Year Est. Return

Euclidean Capital's Q3 2022 Portfolio in Review

As of Q3 2022, Euclidean Capital held 10 positions worth $108M, down 8.4% from $118M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q3 2022: portfolio turnover was 0%. Euclidean Capital opened no new positions and made no exits, leaving the 10-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 97% of assets, down from 97% a quarter earlier, followed by Financials.

  • Euclidean Capital's ten largest holdings make up 100% of its $108M portfolio in Q3 2022.
  • Euclidean Capital opened 0 new positions and closed 0 in Q3 2022.
  • Euclidean Capital's portfolio value fell 8.4% quarter-over-quarter to $108M.

Based on Euclidean Capital's 13F filing for Q3 2022, filed 14 Nov 2022.